No Data
No Data
ProSomnus Contributes Two Scientific Abstracts for Presentation at SLEEP 2024, A Joint Meeting of the American Academy of Sleep Medicine and the Sleep Research Society
PLEASANTON, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (the "Company"), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy, announced that it has contributed two scientific abstracts that
ProSomnus in Peril: Chapter 11 Reorganization Poses Threat to Stock Value and Company Viability
10-Q: Quarterly report
Express News | Prosomnus Announces Strong First Quarter 2024 Revenue Growth
ProSomnus Contributes Two Scientific Abstracts Accepted for Presentation at the 2024 American Academy of Dental Sleep Medicine Annual Meeting
PLEASANTON, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (the "Company"), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy, announced that it has contributed two scientific abs
Four Independent Scientific Abstracts at the American Academy of Dental Sleep Medicine Annual Meeting Feature ProSomnus Intraoral Medical Devices
PLEASANTON, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (the "Company"), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy, announced that four independent scientific abstracts accepted
No Data